No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Angiogenesis Inhibitors* / adverse effects
-
Anterior Chamber
-
Humans
-
Intravitreal Injections
-
Pilot Projects
-
Ranibizumab*
-
Recombinant Fusion Proteins
Substances
-
Angiogenesis Inhibitors
-
Recombinant Fusion Proteins
-
KH902 fusion protein
-
Ranibizumab